Home/Supreme Court/Mylan Pharmaceuticals Inc. v. Eurand, Inc.

Mylan Pharmaceuticals Inc. v. Eurand, Inc.

568 U.S. 1123, 133 S. Ct. 933, 184 L. Ed. 2d 725, 81 U.S.L.W. 3388, 2013 WL 141183, 2013 U.S. LEXIS 846
Supreme Court of the United States·Decided January 14, 2013·No. No. 12-514·Published

Opinion

C. A. Fed. Cir. Certiorari denied.

Free access — add to your briefcase to read the full text and ask questions with AI

Mylan Pharmaceuticals Inc. v. Eurand, Inc., 568 U.S. 1123, 133 S. Ct. 933, 184 L. Ed. 2d 725, 81 U.S.L.W. 3388, 2013 WL 141183, 2013 U.S. LEXIS 846 (2013).

568 U.S. 1123 (Mylan Pharmaceuticals Inc. v. Eurand, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.